Wu Jin-Song, Shou Xue-Fei, Yao Cheng-Jun, Wang Yong-Fei, Zhuang Dong-Xiao, Mao Ying, Li Shi-Qi, Zhou Liang-Fu
Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Neurosurgery. 2009 Jul;65(1):63-70; discussion 70-1. doi: 10.1227/01.NEU.0000348549.26832.51.
To evaluate the applicability of low-field intraoperative magnetic resonance imaging (iMRI) during transsphenoidal surgery of pituitary macroadenomas.
Fifty-five transsphenoidal surgeries were performed for macroadenomas (modified Hardy's Grade II-IV) resections. All of the surgical processes were guided by real-time updated contrast T1-weighted coronal and sagittal images, which were acquired with 0.15 Tesla PoleStar N20 iMRI (Medtronic Navigation, Louisville, CO). The definitive benefits as well as major drawbacks of low-field iMRI in transsphenoidal surgery were assessed with respect to intraoperative imaging, tumor resection control, comparison with early postoperative high-field magnetic resonance imaging, and follow-up outcomes.
Intraoperative imaging revealed residual tumor and guided extended tumor resection in 17 of 55 cases. As a result, the percentage of gross total removal of macroadenomas increased from 58.2% to 83.6%. The accuracy of imaging evaluation of low-field iMRI was 81.8%, compared with early postoperative high-field MRI (Correlation coefficient, 0.677; P < 0.001). A significantly lower accuracy was identified with low-field iMRI in 6 cases with cavernous sinus invasion (33.3%) in contrast to the 87.8% found with other sites (Fisher's exact test, P < 0.001).
The PoleStar N20 low-field iMRI navigation system is a promising tool for safe, minimally invasive, endonasal, transsphenoidal pituitary macroadenomas resection. It enables neurosurgeons to control the extent of tumor resection, particularly for suprasellar tumors, ensuring surgical accuracy and safety, and leading to a decreased likelihood of repeat surgeries. However, this technology is still not satisfying in estimating the amount of the parasellar residual tumor invading into cavernous sinus, given the false or uncertain images generated by low-field iMRI in this region, which are difficult to discriminate between tumor remnant and blood within the venous sinus.
评估低场术中磁共振成像(iMRI)在垂体大腺瘤经蝶窦手术中的适用性。
对55例大腺瘤(改良Hardy分级II-IV级)进行经蝶窦手术切除。所有手术过程均由实时更新的对比增强T1加权冠状位和矢状位图像引导,这些图像通过0.15特斯拉的PoleStar N20 iMRI(美敦力导航公司,路易斯维尔,科罗拉多州)获取。从术中成像、肿瘤切除控制、与术后早期高场磁共振成像的比较以及随访结果等方面评估低场iMRI在经蝶窦手术中的明确益处和主要缺点。
术中成像在55例中的17例显示残留肿瘤并指导扩大肿瘤切除。结果,大腺瘤的全切除率从58.2%提高到83.6%。与术后早期高场MRI相比,低场iMRI成像评估的准确率为81.8%(相关系数,0.677;P<0.001)。在6例海绵窦侵犯的病例中,低场iMRI的准确率显著较低(33.3%),而其他部位为87.8%(Fisher精确检验,P<0.001)。
PoleStar N20低场iMRI导航系统是安全、微创、鼻内、经蝶窦切除垂体大腺瘤的有前景的工具。它使神经外科医生能够控制肿瘤切除范围,特别是对于鞍上肿瘤,确保手术准确性和安全性,并降低再次手术的可能性。然而,鉴于低场iMRI在该区域产生的假图像或不确定图像,难以区分肿瘤残余和静脉窦内的血液,该技术在估计侵犯海绵窦的鞍旁残留肿瘤量方面仍不令人满意。